No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene.
Catechol-o-methyltransferase (COMT) is an enzyme that inactivates biologically active or toxic catechols. Previous studies have yielded inconsistent results on the relationship between erythrocyte COMT activity and affective disorders. Recently an amino acid change (Val-108-Met) of the COMT protein was shown to determine high- and low-activity alleles of the enzyme. Using polymerase chain reaction and the restriction enzyme NLaIII, we genotyped 107 patients with bipolar disorder, 62 with unipolar depression, and 121 controls. Neither bipolar nor unipolar patients differ significantly in the genotypic or allelic frequency from the control group. Even when the bipolar and unipolar patients were pooled into a single group, the distributions of both the genotypes and the alleles for the patient group were similar to those for the controls. We conclude that genetic variation that determines high and low activities of COMT does not have a major effect on the vulnerability to affective disorders in our sample.
Kunugi
H
H
Department of Psychological Medicine, Institute of Psychiatry, London, United Kingdom.
Vallada
H P
HP
Hoda
F
F
Kirov
G
G
Gill
M
M
Aitchison
K J
KJ
Ball
D
D
Arranz
M J
MJ
Murray
R M
RM
Collier
D A
DA
D000328:Adult; D000483:Alleles; D001714:Bipolar Disorder / Q000235:genetics / Q000523:psychology; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D003866:Depressive Disorder / Q000235:genetics / Q000523:psychology; D005838:Genotype; D006801:Humans; D019964:Mood Disorders / Q000235:genetics* / Q000523:psychology; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic
D002394:Catechol O-Methyltransferase